Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
42
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Hang Seng Bank
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Greater China Affluence And Digital Trends Will Unlock New Horizons
Key Takeaways Dominant wealth management and strong cross-border integration position Hang Seng Bank for high-margin income growth and substantial market share gains across Greater Hong Kong and Mainland China. Aggressive digital transformation and early leadership in sustainable finance create long-term operating leverage, efficiency, and a defensible niche supporting shareholder returns.
View narrative
HK$130.73
FV
13.3% undervalued
intrinsic discount
9.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Gladstone Land
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Urban Expansion And Rising Food Demand Will Boost Farmland Appeal
Key Takeaways Strategic farmland sales in urbanizing regions and resilient Western assets position Gladstone Land for unexpected capital gains and strengthened recurring revenues. Long-term demographic shifts, increased crop demand, and preference for inflation-hedged assets support premium rents, enhanced margins, and favorable investor re-rating.
View narrative
US$14.15
FV
37.3% undervalued
intrinsic discount
7.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 17 hours ago
author updated this narrative
CVRx
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Aging Population And Chronic Diseases Will Boost Heart Therapy Adoption
Key Takeaways Accelerated account expansion, effective talent strategies, and disease trends position CVRx for growth exceeding current forecasts and analyst expectations. Advancements in technology, digital integration, and global reach could significantly enhance both revenue quality and longer-term profitability.
View narrative
US$14.00
FV
49.8% undervalued
intrinsic discount
22.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 17 hours ago
author updated this narrative
Alpha Teknova
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Biopharma R&D And Cell Therapy Will Drive Custom Manufacturing
Key Takeaways Scalable infrastructure and advanced manufacturing position Teknova to outperform through new products, automation, and capitalizing on the trend toward outsourced biopharma reagent production. Expansion into personalized medicine and strategic acquisitions enhance growth prospects, while strong fundamentals reduce risk and increase potential for higher valuation and shareholder returns.
View narrative
US$12.00
FV
60.9% undervalued
intrinsic discount
14.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 17 hours ago
author updated this narrative
Quanterix
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Ultra-sensitive Proteomics Will Revolutionize Early Disease Detection Worldwide
Key Takeaways Simoa technology upgrades and operational realignment position the company for dominance in high-margin proteomics and spatial biology markets through expanded adoption and recurring revenue. Aggressive innovation, strategic acquisitions, and cost synergies are expected to accelerate earnings, margins, and new pharma partnerships while capturing a rapidly expanding diagnostics market.
View narrative
US$7.00
FV
34.7% undervalued
intrinsic discount
22.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 17 hours ago
author updated this narrative
Hannover Rück
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Emerging Markets And Climate Trends Will Redefine Reinsurance Opportunities
Key Takeaways Accelerating premium growth, diversified specialty expansion, and strong reserve flexibility position Hannover Rück for outperformance in both earnings and long-term margin stability. Superior capital strength and disciplined management enable above-peer growth, with potential for higher shareholder returns and sustained expansion across high-growth global regions.
View narrative
€340.00
FV
24.7% undervalued
intrinsic discount
3.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Pacific Biosciences of California
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Vega Shipments And Multi-Omics Trends Will Fuel Genomics Breakthroughs
Key Takeaways Accelerated adoption of new platforms and technologies is expanding PacBio's user base, international reach, and revenue diversification opportunities. Advances in product offerings and strategic partnerships are enhancing margins, market positioning, and access to high-growth clinical and precision medicine segments.
View narrative
US$3.00
FV
56.3% undervalued
intrinsic discount
21.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
about 17 hours ago
author updated this narrative
Restaurant Brands Asia
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Digital Rollout And Expansion Will Capture Urban Demand In Asia
Key Takeaways Aggressive digital, AI, and expansion strategies are driving operational efficiency, customer loyalty, and set up for significant gains in sales and profitability. Rapid café innovation, targeted marketing, and supply chain optimization position the company for substantial revenue growth and margin expansion in a rising market.
View narrative
₹125.07
FV
37.0% undervalued
intrinsic discount
18.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 17 hours ago
author updated this narrative
Arteris
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
AI And Automotive Trends Will Drive Advanced Chip Adoption
Key Takeaways Landmark customer wins and accelerating IP outsourcing position Arteris for rapid revenue growth and increased account stickiness amid AI and automotive adoption tailwinds. FlexGen and Magillem Packaging proliferation, validated by industry leaders, set the stage for margin expansion and rising contract values as industry complexity grows.
View narrative
US$16.00
FV
41.3% undervalued
intrinsic discount
18.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 17 hours ago
author updated this narrative
Value any company in seconds
Popular companies